Publique en esta revista
Información de la revista
Vol. 37. Núm. 6.Junio 2001
Páginas 271-327
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 37. Núm. 6.Junio 2001
Páginas 271-327
DOI: 10.1016/S0300-2896(01)75074-0
Guía clínica para el diagnóstico y el tratamiento de la enfermedad pulmonar obstructiva crónica
Visitas
97066
J.A. Barberàa,
Autor para correspondencia
barbera@medicina.ub.es

Correspondencia: Servei de Neumologia. Hospital Clínic. Villarroel, 170. 08036 Barcelona.
, G. Peces-Barbab, A.G.N. Agustíc, J.L. Izquierdod, E. Monsóe, T. Montemayorf, J.L. Viejog
a Servei de Neumologia. Hospital Clínic. Barcelona
b Servei de Neumologia. Fundación Jiménez Díaz. Madrid
c Servei de Neumologia. Hospital Son Dureta. Palma de Mallorca
d Servei de Neumologia. Hospital General. Guadalajara
e Servei de Neumologia. Hospital Germans Trias i Pujol. Badalona. Barcelona
f Servei de Neumologia. Hospital Virgen del Rocío. Sevilla
g Servei de Neumologia. Hospital General Yagüe. Burgos
Grupo de Trabajo de la Sociedad Española de Neumología y Cirugía Torácica (Separ)
Este artículo ha recibido
97066
Visitas
Información del artículo
El Texto completo solo está disponible en PDF
Bibliografía
[1.]
T. Montemayor,I. Alfajeme,C. Escudero,J. Morera,L. Sánchez Agudo
Normativa sobre diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica,
[2.]
T. Montemayor,I. Alfajeme,C. Escudero,J. Morera,L. Sánchez Agudo
Normativa sobre diagnóstico de la enfermedad pulmonar obstructiva crónica
Arch Bronconeumol, 32 (1996), pp. 285-301
[3.]
N.M. Siafakas,P. Vermeire,N.B. Pride,P. Paoletti,J. Gibson,P. Howard
Optimal assessment and management of chronic obstructive pulmonary disease (COPD)
Eur Respir J, 8 (1995), pp. 1398-1420
[4.]
Society American Thoracic
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
Am J Respir Crit Care Med, 152 (1995), pp. S77-S121
[5.]
G.L. Snider,J. Kleinreman,W.M. Thurlbeck,Z.H. Bengali
The definition of emphysema: report of National Heart and Blood Institute, division of Lung Diseases, workshop
Am Rev Respir Dis, 132 (1985), pp. 182-185 http://dx.doi.org/10.1164/arrd.1985.132.1.182
[6.]
American Thoracic Society
Lung function testing: selection of reference values and interpretative strategies
Am Rev Respir Dis, 144 (1991), pp. 1202-1218 http://dx.doi.org/10.1164/ajrccm/144.5.1202
[7.]
British Thoracic Society
Guidelines for the management of chronic obstructive pulmonary disease
Thorax, 52 (1997), pp. S1-S28
[8.]
B.R. Celli
Monitoring the progression of chronic obstructive pulmonary disease: time for a new staging system
Eur Respir Rev, 9 (1999), pp. 165-168
[9.]
B. Celli,C. Cote,M. Marín,M. Montes de Oca,C. Casanova,R. Méndez
The SCORE: a new COPD staging system combining 6MWD, MRC dyspnea. FEV1 and PaO2 as predictor of health care resources utilization (HCUR)
Am J Respir Crit Care Med, 161 (2000), pp. A749
[10.]
V. Sobradillo,M. Miravitlles,C.A. Jiménez,R. Gabriel,J.L. Viejo,J.F. Masa
Estudio IBERPOC en España: prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo
Arch Bronconeumol, 35 (1999), pp. 159-166
[11.]
J.F. Masa,M. Miravitlles,C. Villasante,C.A. Jiménez,J.L. Viejo,L. Fernández-Fau
Underdiagnosis and geographical differences in COPD prevalence in Spain
Am J Respir Crit Care Med, 159 (1999), pp. A921
[12.]
L. Biglino,B. Girón,R. Fernández
Encuesta nacional de salud 1995,
[13.]
V. Sobradillo
Enfermedad pulmonar obstructiva crónica. Enfoque actual
EPOC perspectivas actuales, pp. 3-17
[14.]
Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
Informe del Gabinete de Estudios Sociológicos Bernard Krief. SEPAR, (1995)
[15.]
P. Alonso
Proyecto coste por proceso,
[16.]
M.G. Seneff,D.P. Wagner,R.P. Wagner,J.E. Zimmerman,W.A. Knaus
Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease
Jama, 274 (1995), pp. 1852-1857
[17.]
J.C. Hogg,P.T. Macklem,W.M. Thurlbeck
Site and nature of airway obstruction in chronic obstructive lung disease
N Engl J Med, 278 (1968), pp. 1355-1360 http://dx.doi.org/10.1056/NEJM196806202782501
[18.]
M.G. Cosio,H. Ghezzo,J.C. Hogg,R. Corbin,M. Loveland,J. Dosman
The relations between structural changes in small airways and pulmonary function tests
N Engl J Med, 298 (1978), pp. 1277-1281 http://dx.doi.org/10.1056/NEJM197806082982303
[19.]
R. Filkenstein,R.S. Fraser,H. Ghezzo,M.G. Cosio
Alveolar inflammation and its relation to emphysema in smokers
Am J Respir Crit Care Med, 152 (1995), pp. 1666-1672 http://dx.doi.org/10.1164/ajrccm.152.5.7582312
[20.]
T.C. O'Shaughnessy,T.W. Ansari,N.C. Barnes,P.K. Jeffery
Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1
Am J Respir Crit Care Med, 155 (1997), pp. 852-857 http://dx.doi.org/10.1164/ajrccm.155.3.9117016
[21.]
M. Saetta,A. Di-Stefano,G. Turato,F.M. Facchini,L. Corbino,C.E. Mapp
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease
Am J Respir Crit Care Med, 157 (1998), pp. 822-826 http://dx.doi.org/10.1164/ajrccm.157.3.9709027
[22.]
V.I. Peinado,J.A. Barberà,P. Abate,J. Ramírez,J. Roca,S. Santos
Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease
Am J Respir Crit Care Med, 159 (1999), pp. 1605-1611 http://dx.doi.org/10.1164/ajrccm.159.5.9807059
[23.]
D.S. Robinson,Q. Hamid,S. Ying,A. Tsicopoulos,J. Barkans,A.M. Bentley
Predominant TH2-like broncho-alveolar T-lymphocite population in atopic asthma
N Engl J Med, 326 (1992), pp. 298-304 http://dx.doi.org/10.1056/NEJM199201303260504
[24.]
M. Humbert,S.R. Durham,S. Ying,P. Kimmitt,J. Barkans,B. Assoufi
IL-4 and IL-5 mRNA and protein in bronchial biopsies from atopic and non atopic asthma. Evidence against “intrinsic” asthma beign a distinct immunopathological entity
Am J Respir Crit Care Med, 154 (1996), pp. 1497-1504 http://dx.doi.org/10.1164/ajrccm.154.5.8912771
[25.]
V.M. Keatings,P.D. Collins,D.M. Scott,P.J. Barnes
Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma
Am J Respir Crit Care Med, 153 (1996), pp. 530-534 http://dx.doi.org/10.1164/ajrccm.153.2.8564092
[26.]
A.T. Hill,D. Bayley,R.A. Stockley
The interrelationship of sputum inflammatory markers in patients with chronic bronchitis
Am J Respir Crit Care Med, 160 (1999), pp. 893-898 http://dx.doi.org/10.1164/ajrccm.160.3.9901091
[27.]
M.R. Lang,G.W. Fiaux,M. Gilooly,J.A. Stewart,D.J.S. Hulmes,D. Lamb
Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs
Thorax, 49 (1994), pp. 319-326
[28.]
W. Timens,W. Coers,J.F.M. Van Straten,D.S. Postma
Extracellular matrix and inflammation: a role of fibroblast-mediated tissue repair in the pathogenesis of emphysema
Eur Respir Rev, 7 (1997), pp. 119-123
[29.]
W.D. Kim,D.H. Eidelman,J.L. Izquierdo,H. Ghezzo,M.P. Saetta,M.G. Cosio
Centrilobular and panlobular emphysema in smokers. Two distinct morphologic and functional entities
Am Rev Respir Dis, 144 (1991), pp. 1385-1390 http://dx.doi.org/10.1164/ajrccm/144.6.1385
[30.]
J.A. Barberà,A. Riverola,J. Roca,J. Ramírez,P.D. Wagner,D. Ros
Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease
Am J Respir Crit Care Med, 149 (1994), pp. 423-429 http://dx.doi.org/10.1164/ajrccm.149.2.8306040
[31.]
V.I. Peinado,J.A. Barberà,J. Ramírez,F.P. Gómez,J. Roca,L. Jover
Endothelial dysfunction in pulmonary arteries of patients with mild COPD
Am J Physiol, 274 (1998), pp. L908-L913
[32.]
A.T. Dinh-Xuan,T.W. Higenbottam,C.A. Clelland,J. Pepke-Zaba,G. Cremona,A.Y. Butt
Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease
N Engl J Med, 324 (1991), pp. 1539-1547 http://dx.doi.org/10.1056/NEJM199105303242203
[33.]
R. Pérez-padilla,J. Regalado,S. Vedal,P. Paré,R. Chapela,R. Sansores
Exposure to biomass smoke of chronic airway disease in Mexican women. A case-control study
Am J Respir Crit Care Med, 154 (1996), pp. 701-706 http://dx.doi.org/10.1164/ajrccm.154.3.8810608
[34.]
C. Fletcher,R. Peto
The natural history of chronic airflow obstruction
Brit Med J, 1 (1977), pp. 1645-1648
[35.]
N. Wolkove,E. Dajczman,A. Colacone,H. Kreisman
The relationship between pulmonary function and dyspnea in obstructive lung disease
Chest, 96 (1989), pp. 1247-1251
[36.]
G.A.V. Borg
Psychophysical basis of perceived exertion
Med Sci Sports Exerc, 14 (1982), pp. 377-381
[37.]
D.A. Mahler,D.H. Weinberg,C.K. Wells,A.R. Feinstein
The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes
Chest, 85 (1984), pp. 751-758
[38.]
D.A. Mahler,R.A. Rosiello,A. Harver,T. Lentine,J.F. McGovern,J.A. Daubenspeck
Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease
Am Rev Respir Dis, 165 (1987), pp. 1229-1233
[39.]
S. Kesten,K.R. Chapman
Physician perceptions and management of COPD
Chest, 104 (1993), pp. 254-258
[40.]
A.M.W.J. Schols,J. Slangen,L. Volovics,E.F.M. Wouters
Weight loss in a reversible factor in the prognosis of chronic obstructive pulmonary disease
Am J Respir Crit Care Med, 157 (1998), pp. 1791-1797 http://dx.doi.org/10.1164/ajrccm.157.6.9705017
[41.]
P.S. Burge,P.M. Calverley,J.M.E. Daniels
The acute effects of oral prednisolone in patients with COPD in the ISOLDE trial: responders and non-responders
Am J Respir Crit Care Med, 153 (1996), pp. A126
[42.]
J.D. Cooper,G.A. Patteson,R.S. Sundaresan,E.P. Trulock,R.D. Yusen,M.S. Pohl
Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema
J Thorac Cardiovascular Surg, 112 (1996), pp. 1319-1329
[43.]
D.E. O'Donnell,M. Lam,K.A. Webb
Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease
Am J Respir Crit Care Med, 158 (1998), pp. 1557-1565 http://dx.doi.org/10.1164/ajrccm.158.5.9804004
[44.]
A.G.N. Agustí,J. Cotes,P.D. Wagner
Responses to exercise in lung diseases
Eur Respir Mon, 6 (1998), pp. 32-50
[45.]
E.M. Baarends,A.M.W.J. Schols,R. Mostert,E.F.M. Wouters
Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease
Eur Respir J, 10 (1997), pp. 2807-2813
[46.]
G.T. Ferguson,E. Fernández,M.R. Zamora,M. Pomerantz,J. Buichholz,B.J. Make
Improved exercise performance following lung volume reduction surgery for emphysema
Am J Respir Crit Care Med, 157 (1998), pp. 1195-1203 http://dx.doi.org/10.1164/ajrccm.157.4.9705008
[47.]
B. Togores,A.G.N. Agustí
Trastornos respiratorios durante el sueño en la enfermedad pulmonar obstructiva crónica
Arch Bronconeumol, 32 (1996), pp. 32-39
[48.]
N.J. Douglas,D.C. Flenley
Breathing during sleep in patients with obstructive lung disease
Am Rev Respir Dis, 141 (1990), pp. 1055-1070 http://dx.doi.org/10.1164/ajrccm/141.4_Pt_1.1055
[49.]
J.J. Connaughton,J.R. Catterall,R.A. Elton,J.R. Stradling,N.J. Douglas
Do sleep studies contribute to the management of patients with severe chronic obstructive pulmonary disease?
Am Rev Respir Dis, 138 (1988), pp. 341-344 http://dx.doi.org/10.1164/ajrccm/138.2.341
[50.]
E.C. Fletcher,R.A. Luckekett,W. Goodnight,C.C. Miller,W. Quian,C. Costarangos-Galarza
A double blind trial of nocturnal supplement oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mmHg
Am Rev Respir Dis, 145 (1992), pp. 1070-1076 http://dx.doi.org/10.1164/ajrccm/145.5.1070
[51.]
W.M. Thurlbeck,G. Simon
Radiographic appearance of the chest in emphysema
Am J Roentgenol, 130 (1978), pp. 429-440
[52.]
C. Sanders
The radiographic diagnosis of emphysema
Radiol Clin North Am, 29 (1991), pp. 1019-1030
[53.]
K.G. Chetty,S.E. Brown,R.W. Light
Identification of pulmonary hypertension in chronic obstructive pulmonary disease from routine chest radiographs
Am Rev Respir Dis, 126 (1982), pp. 338-341 http://dx.doi.org/10.1164/arrd.1982.126.2.338
[54.]
D.M. Skillrid,K.P. Offord,R.D. Miller
Higher risk of lung cancer in chronic pulmonary disease. A prospective matched case-controlled study
Ann Intern Med, 105 (1986), pp. 503-507
[55.]
J.S. Klein,G. Gamsu,W.R. Webb,J.A. Golden,N.L. Muller
High-resolution CT diagnosis of emphysema in symptomatic patients with normal chest radiographs and isolated low diffusing capacity
[56.]
K. Kuwano,K. Matsuba,T. Ikeda
The diagnosis of mild emphysema. Correlation of computed tomography and pathology scores
Am Rev Respir Dis, 141 (1990), pp. 169-178 http://dx.doi.org/10.1164/ajrccm/141.1.169
[57.]
G.H. Guyatt,M. Townsend,L.B. Bermas,S.O. Pugsley
Quality of life in patients with chronic airflow limitation
Br J Dis Chest, 81 (1987), pp. 45-54
[58.]
P.W. Jones,F.H. Quirk,C.M. Baveystock,P. Littlejohns
A selfcomplete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire
Am Rev Respir Dis, 145 (1992), pp. 1321-1327 http://dx.doi.org/10.1164/ajrccm/145.6.1321
[59.]
R. Güell,P. Casan,M. Sangenis
Traducción española y validación de un cuestionario de calidad de vida en pacientes con enfermedad pulmonar obstructiva crónica
Arch Bronconeumol, 31 (1995), pp. 202-210
[60.]
M. Ferrer,J. Alonso,L. Prieto
Validity and reliability of the St. George's Respiratory Questionnaire after adaptation to a different language and culture: The Spanish example
Eur Respir J, 9 (1996), pp. 1160-1166
[61.]
P.W. Jones
Health status in chronic obstructive pulmonary disease
Eur Respir Rev, 9 (1999), pp. 169-172
[62.]
N.R. Anthonisen,J.E. Connett,J.P. Kiley,M.D. Altose,W.C. Bailey,S.A. Buist
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study
Jama, 272 (1994), pp. 1497-1505
[63.]
C.A. Jiménez,S. Solano,J.M. González de Vega,M.J. Ruiz,P. Flórez,A. Ramos
Normativa para el tratamiento del tabaquismo
Arch Bronconeumol, 35 (1999), pp. 499-506
[64.]
C. Silagy,M.D. Fowler,M. Lodge
Meta-analysis of efficacy of nicotine replacement therapies in smoking cessation
Lancet, 343 (1994), pp. 139-142
[65.]
T. Blondal,L.J. Gudmundsson,I. Olafsdottir,A. Westin
Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up
Brit Med J, 318 (1999), pp. 285-289
[66.]
R.D. Hurt,D.P.L. Sachs,D.E. Glover,K.P. Offord,J.A. Johnston,P.D. Lowell
A comparison of sustained-release bupropion and placebo for smoking cessation
N Engl J Med, 337 (1997), pp. 1195-1202 http://dx.doi.org/10.1056/NEJM199710233371703
[67.]
D.E. Jorenby,S.J. Leischow,M.A. Nides,S.I. Rennard,J.A. Johnston,A.R. Hughes
A controlled trial of sustained bupropion, a nicotine patch, or both for smoking cessation
N Engl J Med, 340 (1999), pp. 685-691 http://dx.doi.org/10.1056/NEJM199903043400903
[68.]
S.G. Glurlay,L.F. Stead,N.L. Benowitz
Clinidine for smoking cessation (Cochrane Review)
The Cochrane Library,
[69.]
Udhhs
The health consequences of smoking: nicotine addiction: a report of the surgeon general
Dhhs Cdc 88–8406,
[70.]
A.R. White,H. Rampes
Acupunture in smoking cessation (Cochrane Review)
The Cochrane Library,
[71.]
K.L. Nichol,K.L. Margolis,J. Wuorenna,T. Von Stember
The efficacy and cost effectiveness of vaccination agaisnt influenza among elderly persons living in the community
N Engl J Med, 331 (1994), pp. 778-784 http://dx.doi.org/10.1056/NEJM199409223311206
[72.]
A. Örtqvist,J. Hedlund,L.A. Burman,E. Elbel,M. Hófer,M. Leinonen
Randomized trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people
Lancet, 351 (1998), pp. 399-403
[73.]
N.R. Anthonisen
OM-85 for COPD
Am J Respir Crit Care Med, 156 (1997), pp. 1713-1714 http://dx.doi.org/10.1164/ajrccm.156.6.ed15-97
[74.]
J. Hay,P. Stone,J. Carter,S. Church
Bronchodilator reversibility, exercice performance and brethlessness in stable obstructive pulmonary disease
Eur Respir J, 5 (1992), pp. 659-664
[75.]
J. Fernández,J.L. Izquierdo
Evaluación de la respuesta broncodilatadora con agonistas beta en pacientes con enfermedad pulmonar obstructiva crónica
Arch Bronconeumol, 31 (1995), pp. 270-275
[76.]
P.J. Barnes
New developments in anticholinergic drugs
Eur Respir Rev, 6 (1996), pp. 290-294
[77.]
COMBIVENT Inhalation Solution Study Group
Routine nebulized ipratropium and albuterol together are better than either alone in COPD
Chest, 112 (1997), pp. 1514-1521
[78.]
M. Cazzola,M.G. Matera
Should long acting beta-2-agonist be considered an alternative first choice option for the treatment and stable COPD?
Respir Med, 93 (1999), pp. 227-229
[79.]
S. Appleton,B. Smith,A. Veale,A. Bara
Regular long-acting beta-2 adrenoceptor agonists in stable chronic obstructive airways disease (Cochrane Review),
[80.]
D.A. Mahler,J.F. Donohue,R.A. Barbee,M.D. Goldman,M.J. Gross,M.E. Wisniewski
Efficacy of salmeterol xinafoate in the treatment of COPD
Chest, 115 (1999), pp. 957-965
[81.]
M.T. Newhouse
Is theophylline obsolete?
Chest, 98 (1990), pp. 1-3
[82.]
J.W. Jenne
Teophylline is no more obsolete than two puffs qid of current beta-2 agonists
Chest, 98 (1990), pp. 3-4
[83.]
D.E. Niewoehner
Theophylline therapy. A continuing dilemma
Chest, 98 (1990), pp. 5
[84.]
D. Murciano,M. Aubier,R. Pariente
A randomized controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease
N Engl J Med, 320 (1989), pp. 1521-1525 http://dx.doi.org/10.1056/NEJM198906083202304
[85.]
J. Iravani,G.N. Melville
Theophylline and mucocilliary function
Chest, 92 (1987), pp. 38S-48S
[86.]
R.A. Matthay,D.A. Mahler
Theophylline improves global cardiac function and reduces dyspnea in chronic obstructive lung disesase
J Allergy Clin Immunol, 78 (1986), pp. 793-799
[87.]
N. Viires,M. Aubier,D. Murciano,B. Fleury,C. Talamo,R. Pariente
Effects of aminophylline on diaphragmatic fatigue during acute respiratory failure
Am Rev Respir Dis, 129 (1984), pp. 396-404 http://dx.doi.org/10.1164/arrd.1984.129.3.396
[88.]
M. Taccola,L. Cancalari,G. Ghignoni,P.L. Paggiaro
Salmeterol versus slow-release theophylline in patients with reversible obstructive pulmonary disease
Monaldi Arch Chest Dis, 54 (1999), pp. 302-306
[89.]
J. Ramsdell
Use of theophylline in the treatment of COPD
Chest, 107 (1995), pp. 206S-209S
[90.]
J.L. Izquierdo,M. Gutiérrez
Corticoides inhalados en la EPOC
Arch Bronconeumol, 35 (1999), pp. 365-366
[91.]
P.S. Burge
EUROSCOP, ISOLDE and the Copenhagen city lung study
Thorax, 54 (1999), pp. 287-288
[92.]
J. Vestbo,T. Sorensen,P. Lante,A. Brix,P. Torre,Viskum
Longterm effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial
Lancet, 353 (1999), pp. 1819-1823
[93.]
R.A. Pauwels,C.G. Lofdahl,L.A. Laitinen,J.P. Schouten,D. Postma,N.B. Pride
Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking
N Engl J Med, 340 (1999), pp. 1948-1953 http://dx.doi.org/10.1056/NEJM199906243402503
[94.]
P.L. Paggiaro,R. Dahle,I. Bakran,L. Frith,K. Hollingworth,J. Efhimiou
Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease
Lancet, 351 (1998), pp. 773-780
[95.]
P.S. Burge,P.M.A. Calverley,P.W. Jones,S. Spencer,J.A. Anderson,T.K. Maslen
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
Brit Med J, 320 (2000), pp. 1297-1303
[96.]
C.M. Callahan,R.S. Dittus,B.P. Katz
Oral corticosteroid theraphy for patients with stable chronic obstructive pulmonary disease. A meta-analysis
Ann Intern Med, 114 (1991), pp. 216-223
[97.]
American Thoracic Society
Guidelines for the approach to the patient with severe hereditary alpha 1-antitripsin deficiency
Am Rev Respir Dis, 27 (1989), pp. 1494-1497
[98.]
M. Miravitlles,R. Vidal,J.C. Barros-Tizón,A. Bustamente,P.P. España,F. Casas
Estado actual del tratamiento sustitutivo en el enfisema congénito por déficit de alfa-1-antitripsina. Informe del registro nacional
Arch Bronconeumol, 35 (1999), pp. 446-454
[99.]
Alpha-1-Antitrypsin Deficiency Registry Study Group
Survival and FEV1 decline in individuals with severe deficiency of alpha- 1-antitrypsin
Am J Respir Crit Care Med, 158 (1998), pp. 49-59 http://dx.doi.org/10.1164/ajrccm.158.1.9712017
[100.]
N. Seersholm,M. Wencker,N. Banik
Does alpha-1 antitrypsin augmentation therapy slow the annual decline in FEV1 in pattients with severe hereditary alpha 1-antitrypsin deficiency?
Eur Respir J, 10 (1997), pp. 2260-2263
[101.]
R. Bhagat,V. Swystun,D.W. Cockcroft
Clinical trials needed for alpha-1-antitrypsin replacement therapy
Chest, 108 (1995), pp. 586-595
[102.]
P.A. Bardsley
Chronic respiratory failure in COPD: is there a place for a respiratory stimulant?
Thorax, 48 (1993), pp. 781-784
[103.]
P.J. Poole,P. Black
Mucolytic agents for chronic bronchitis (Cochrane Review)
The Cochrane Library,
[104.]
E.M. Grandjean,P. Berthet,R. Ruffmann,P. Leuenberger
Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled trials
[105.]
M.P. De Lucas,R. Güell,V. Sobradillo,C. Jiménez,M. Sangenis,T. Montemayor
Normativa sobre la rehabilitación respiratoria
Arch Bronconeumol, 36 (2000), pp. 257-274
[106.]
R. Güell,P. Casan,J.A. García
Rehabilitación respiratoria
Arch Bronconeumol, 30 (1994), pp. 63-113
[107.]
American College of Chest Physicians, American Association of Cardiovascular and Pulmonary Rehabilitation Guidelines Panel
Pulmonary rehabilitation: Joing ACCP/AACVPR evidence-based guidelines
Chest, 112 (1997), pp. 1363-1396
[108.]
T. Montemayor,H. Sánchez,F. Ortega
Rehabilitación respiratoria
Manual de neumología y cirugía torácica, pp. 619-641
[109.]
J.A. Wedzicha,J.C. Bestall,R. Garrod,R. Tarnham,E.A. Paul,P.W. Jones
Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale
Eur Respir J, 12 (1998), pp. 363-369
[110.]
Y. Lacasse,E. Wong,G.H. Guyatt,D. King,D.J. Cook,R.S. Goldstein
Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease
Lancet,, 348 (1996), pp. 1115-1119
[111.]
W. Cambach,R.C. Wagenaar,T.W. Koelman,A.R. Van Keimpema,H.C. Kemper
The longterm effects of pulmonary rehabilitation in patients with asthma and chronic obstructive pulmonary disease: a research synthesis. Meta-analysis
Arch Phys Med Rehabil, 1 (1999), pp. 103-111
[112.]
A.L. Hamilton,K.J. Killian,E. Summers,N.L. Jones
Muscle strenght, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders
Am J Respir Crit Care Med, 152 (1995), pp. 2021-2031 http://dx.doi.org/10.1164/ajrccm.152.6.8520771
[113.]
R. Gosselink,T. Troosters,M. Decramer
Peripheral muscle weakness contributes to exercise limitation in COPD
Am J Respir Crit Care Med, 153 (1996), pp. 976-980 http://dx.doi.org/10.1164/ajrccm.153.3.8630582
[114.]
S. Bernard,P. Leblanc,F. Whittom,M.G. Carrier,J. Jobin,R. Belleau
Peripheral muscle weakness in patients with chronic obstructive pulmonary disease
Am J Respir Crit Care Med, 158 (1998), pp. 629-634 http://dx.doi.org/10.1164/ajrccm.158.2.9711023
[115.]
K. Simpson,K. Killian,N. McCartrey,D.G. Stubbing,N.L. Jones
Randomised controlled trial of weight-lifting exercise in patients with chronic airflow limitation
Thorax, 47 (1992), pp. 70-75
[116.]
S. Bernard,F. Whittom,P. Leblanc,J. Jobin,R. Belleau,C.H. Berube
Aerobic and strenght training in patients with chronic obstructive pulmonary disease
Am J Respir Crit Care Med, 159 (1999), pp. 896-901 http://dx.doi.org/10.1164/ajrccm.159.3.9807034
[117.]
J. Toral,F. Ortega,P. Cejudo,R. Villagómez,H. Sánchez,J. Castillo
Comparación entre diferentes modalidades de entrenamiento muscular periférico en la rehabilitación de pacientes con EPOC estables
Arch Bronconeumol, 35 (1999), pp. 1S
[118.]
K. Smith,D. Cook,G.H. Guyatt,J. Madhavan,A.D. Oxman
Respiratory muscle training in chronic airflow limitation: a metaanalysis
Am Rev Respir Dis, 145 (1992), pp. 533-539 http://dx.doi.org/10.1164/ajrccm/145.3.533
[119.]
C. Lisboa,V. Muñoz,T. Beroiza,A. Leiva,E. Cruz
Inspiratory muscle training in chronic airflow limitation: comparison of two different training loads using a threshold device
Eur Respir J, 7 (1994), pp. 1266-1274
[120.]
P. De Lucas,J.M. Rodrígues González-Moro,J. García de Pedro,A. Santacruz,E. Tatay,J.M. Cubillo
Entrenamiento de los músculos inspiratorios en la enfermedad pulmonar obstructiva crónica: su repercusión en parámetros funcionales y tolerancia al ejercicio
Arch Bronconeumol, 34 (1998), pp. 64-70
[121.]
P. Cejudo,H. Sánchez,F. Ortega,J. Toral,R. Villagómez,T. Montemayor
Home ventilatory muscle training in patients with chronic obstructive pulmonary disease (COPD)
Eur Respir J, 12 (1988), pp. 3S
[122.]
I.M. Ferreira,D. Brooks,Y. Lacasse,R.S. Goldstein
Nutritional support for individuals with COPD: a meta-analysis
Chest, 117 (2000), pp. 672-678
[123.]
P.J. Wijkstra,R. Van Altena,J. Kraan,V. Otten,D.S. Postma,G.H. Koeter
Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation in the home
Eur Respir J, 7 (1994), pp. 269-273
[124.]
J.H. Strijbos,D.S. Postma,R. Van Altena,F. Gimeno,G.H. Koeter
A comparison between an outpatient hospital-based pulmonary rehabilitation program and a home-care rehabilitation program in patients with COPD
Chest, 109 (1996), pp. 366-372
[125.]
J.H. Gravil,O.A. Al Rawas,M.M. Cotton,U. Flanigan,A. Irvin,R.D. Stevenson
Home treatment of exarcerbations of chronic obstructive pulmonary disease by an acute respiratory assessment service
Lancet, 351 (1998), pp. 1853-1855
[126.]
S. Shepperd,D. Harwood,A. Gray,M. Vessey,P. Morgan
Randomised controlled trial comparing hospital at home care with inpatient hospital care. II: cost minimisation analysis
Brit Med J, 316 (1998), pp. 1791-1796
[127.]
Medical Research Council Working Party
Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema
Lancet, 1 (1981), pp. 681-686
[128.]
Nocturnal Oxygen Therapy Group
Continous or nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease: a clinical trial
Ann Intern Med, 93 (1980), pp. 391-398
[129.]
L. Sánchez-Agudo,R. Cornudella,R. Estopà,L. Molinos,E. Servera
Normativa para la indicación y empleo de la oxigenoterapia continua domiciliaria (OCD)
Arch Bronconeumol, 34 (1998), pp. 87-94
[130.]
A. Chaouat,E. Weitzenblum,R. Kessler,C. Charpentier,M. Enrhart,R. Schott
A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients
Eur Respir J, 14 (1999), pp. 1002-1008
[131.]
F. Smeets
Travel for technology-dependent patients with respiratory disease
Thorax, 49 (1994), pp. 77-81
[132.]
J.D. Hosenpud,L.E. Bennett,B.M. Keck,B. Fiol,M.M. Boucek,R.J. Novick
The Registry of the Internationl Society for Heart and Lung Transplantation: fifteenth official report-1998
J Heart Lung Transplant, 17 (1998), pp. 656-668
[133.]
E.P. Trulock
Lung transplantation
Am J Respir Crit Care Med, 155 (1997), pp. 789-818 http://dx.doi.org/10.1164/ajrccm.155.3.9117010
[134.]
J.D. Hosenpud,L.E. Bennet,B.M. Keck,E.B. Edwards,R.J. Novick
Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease
[135.]
G.A. Patterson,J.R. Maurer,T.J. Williams,P.G. Cardoso,M. Scavuzzo,T.R. Todd
Comparison of outcomes of double and single lung transplantation for obstructive lung disease. The Toronto Lung Transplant Group
J Thorac Cardiovasc Surg, 101 (1991), pp. 623-631
[136.]
R.D. Levy,P. Ernst,S.M. Levine,H. Shennib,A. Anzueto,C.L. Bryan
Exercise performance after lung transplantation
J Heart Lung Transplant, 12 (1993), pp. 27-33
[137.]
C.R. Gross,K. Savik,R.M. Bolman,M.I. Hertz
Long-term health status and quality of life outcomes of lung transplant recipients
Chest, 108 (1995), pp. 1587-1593
[138.]
A. Varela,A. Román,P. De Lucas,P. Morales,R. Lama,M.C. Carreño
Normativa sobre el estudio y seguimiento del receptor de un trasplante pulmonar,
[139.]
J.R. Maurer,A.E. Frost,M. Estenne,T. Higenbottam,A.R. Glanville
International guidelines for the selection of lung transplant candidates
J Heart Lung Transplant, 17 (1998), pp. 703-709
[140.]
J.D. Cooper,E.P. Trulock,A.N. Triantafillou,G.A. Patterson,M.S. Pohl,P.A. Deloney
Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease
J Thorac Cardiovasc Surg, 109 (1995), pp. 106-116 http://dx.doi.org/10.1016/S0022-5223(95)70426-4
[141.]
A.M. Fein,S.S. Branman,R. Casaburi,C.G. Irvin,B.J. Make,J.R. Rodarte
Lung volume reduction surgery
Am J Respir Crit Care Med, 154 (1996), pp. 1151-1152 http://dx.doi.org/10.1164/ajrccm.154.4.8887620
[142.]
The National Emphysema Treatment Trial Research Group
Rationale and design of the National Emphysema Treatment Trial: a prospective randomized trial of lung volume reduction surgery
Chest, 116 (1999), pp. 1750-1761
[143.]
D. Geddes,M. Davies,H. Koyama,D. Hansell,U. Pastorino,J. Pepper
Effect of lung-volume-reduction surgery in patients with severe emphysema
N Engl J Med, 343 (2000), pp. 239-245 http://dx.doi.org/10.1056/NEJM200007273430402
[144.]
E.W. Russi,U. Stammberger,W. Weder
Lung volume reduction surgery for emphysema
Eur Respir J, 10 (1997), pp. 208-218
[145.]
A.F. Gelb,R.J.J. McKenna,M. Brenner,M.J. Schein,N. Zamel,R. Fischel
Lung function 4 years after lung volume reduction surgery for emphysema
Chest, 116 (1999), pp. 1608-1615
[146.]
R.M. Slone,T.K. Pilgram,D.S. Gierada,S.S. Sagel,H.S. Glazer,R.D. Yusen
Lung volume reduction surgery: comparison of preoperative radiologic features and clinical outcome
[147.]
R.D. Yusen,S.S. Lefrak,E.P. Trulock
Evaluation and preoperative management of lung volume reduction surgery candidates
Clin Chest Med, 18 (1997), pp. 199-224
[148.]
G.L. Snider
Reduction pneumoplasty for giant bullous emphysema. Implications for surgical treatment of nonbullous emphysema
Chest, 109 (1996), pp. 540-548
[149.]
M.C. Marshall,G.N. Olsen
The physiologic evaluation of the lung resection cadidate
Clin Chest Med, 14 (1993), pp. 305-320
[150.]
C.T. Bolliger,A.P. Perruchoud
Functional evaluation of the lung resection candidate
Eur Respir J, 11 (1998), pp. 198-212
[151.]
J. Markos,B.P. Mullan,D.R. Hillman,A.W. Musk,V.F. Antico,F.T. Lovegrove
Preoperative assessment as a predictor of mortality and morbility after lung resection
Am Rev Respir Dis, 139 (1989), pp. 902-910 http://dx.doi.org/10.1164/ajrccm/139.4.902
[152.]
J. Ribas,O. Díaz,J.A. Barberà,M. Mateu,E. Canalis,L. Jover
Invasive exercise testing in the evaluation of patients at high-risk for lung resection
Eur Respir J, 12 (1998), pp. 1429-1435
[153.]
R.J. Landreneau,D.J. Surgarbaker,M.J. Mack,S.R. Hazelrigg,J.D. Luketich,L. Fetterman
Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer
J Thorac Cardiovasc Surg, 113 (1997), pp. 691-698 http://dx.doi.org/10.1016/S0022-5223(97)70226-5
[154.]
E.M. Tschernko,S. Hofer,C. Bieglmayer,W. Wisser,W. Haider
Early postoperative stress: viedo-assisted wedge resection/lobectomy vs conventional axillary thoracotomy
Chest, 109 (1996), pp. 1636-1642
[155.]
C.T. Bolliger,P. Jordan,M. Soler,P. Stulz,E. Gradel,K. Skarvan
Exercise capacity as a predictor of postoperative complications in lung resection candidates
Am J Respir Crit Care Med, 151 (1995), pp. 1472-1480 http://dx.doi.org/10.1164/ajrccm.151.5.7735602
[156.]
N. Soler,A. Torres,S. Ewig,J. González,R. Celis,M. El-Biary
Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation
Am J Respir Crit Care Med, 157 (1998), pp. 1498-1505 http://dx.doi.org/10.1164/ajrccm.157.5.9711044
[157.]
J.T. MacFarlane,A. Colville,A. Guion,R.M. MacFarlane,D.H. Rose
Prospective study of aetiology and outcome of adult lowerrespiratory tract infections in the community
Lancet, 341 (1993), pp. 511-514
[158.]
G.J. Huchon,G. Gialdroni-Grassi,P. Leophonte,F. Manresa,T. Schaberg,M. Woodhead
Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey
Eur Respir J, 9 (1996), pp. 1590-1595
[159.]
X. Xu,L. Wang
Association of indoor and outdoor particulate pollution level with chronic respiratory illness
Am Rev Respir Dis, 148 (1993), pp. 1516-1522 http://dx.doi.org/10.1164/ajrccm/148.6_Pt_1.1516
[160.]
D.P. Tashkin,R. Detels,M. Simmons
The UCLA population studies of chronic obstructive pulmonary disease. XI. Impact of air pollution and smoking on annual change in forced expiratory volume in one second
Am J Respir Crit Care Med, 149 (1994), pp. 1067-1083
[161.]
G.H. Murata,M.S. Gorby,T.W. Chick,A.K. Halperin
Use of emergency medical services by patients with decompensated obstructive lung disease
Ann Emerg Med, 18 (1989), pp. 501-506
[162.]
D.S. Postma
When can an exacerbation of COPD be trated at home?
Lancet, 351 (1998), pp. 1827-1828
[163.]
N.H. Gross,T.L. Petty,M. Friedman
Dose-response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease
Am Rev Respir Dis, 139 (1989), pp. 1185-1191
[164.]
P. Moayyedi,J. Congleton,R.L. Page,S.B. Pearson,M.H. Muers
Comparison of nebulised salbutamol and ipratropium bromide with salbutamil alone in the treatment of chronic obstructive pulmonary disease
Thorax, 50 (1995), pp. 834-837
[165.]
N.R. Anthonisen,J. Manfreda,C.P.W. Warren,E.S. Hershfield,G.K. Harding,N.A. Nelson
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
Ann Intern Med, 106 (1987), pp. 196-204
[166.]
S. Saint,S. Bent,E. Wittinghoff
Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis
Jama, 273 (1995), pp. 957-960
[167.]
P. Ball
Epidemiology and treatment of chronic bronchitis and its exacerbations
Chest, 108 (1995), pp. 43S-52S
[168.]
R.K. Albert,T.R. Martin,S.W. Lewis
Controlled clinical trials of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency
Ann Intern Med, 92 (1980), pp. 753-758
[169.]
L. Davies,R.M. Angus,P.M. Calverley
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial
Lancet, 354 (1999), pp. 456-460
[170.]
D.E. Niewoehner,M.L. Erbland,R.H. Deupree,D. Collins,N.J. Gross,R.W. Light
Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group
N Engl J Med, 340 (1999), pp. 1941-1947 http://dx.doi.org/10.1056/NEJM199906243402502
[171.]
C.L. Emerman,D. Effron,T.W. Lukens
Spirometric criteria for hospital admission of patients with acute exacerbation of COPD
Chest, 99 (1991), pp. 595-599
[172.]
R. Kessler,M. Faller,G. Fourgaut,B. Mennecier,E. Weitzenblum
Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease
Am J Respir Crit Care Med, 159 (1999), pp. 158-164 http://dx.doi.org/10.1164/ajrccm.159.1.9803117
[173.]
A.F.J. Connors,N.V. Dawson,C. Thomas
Outcomes following acute exacerbations of severe chronic obstructive lung disease
Am J Respir Crit Care Med, 154 (1996), pp. 959-967 http://dx.doi.org/10.1164/ajrccm.154.4.8887592
[174.]
J.A. Barberà,J. Roca,A. Ferrer,M.A. Félez,O. Díaz,N. Roger
Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease
Eur Respir J, 10 (1997), pp. 1285-1291
[175.]
A.G.N. Agustí,M. Carrera,F. Barbé,A. Muñoz,B. Togores
Oxygen therapy during exacerbations of chronic obstructive pulmonary disease
Eur Respir J, 14 (1999), pp. 934-939
[176.]
M. Aubier,D. Murciano,M. Fournier,J. Milic-Emili,R. Pariente,J.P. Derenne
Central respiratory drive in acute respiratory failure of patients with chronic obstructive pulmonary disease
Am Rev Respir Dis, 122 (1980), pp. 191-200 http://dx.doi.org/10.1164/arrd.1980.122.2.191
[177.]
M. Aubier,D. Murciano,J. Milic-Emili,E. Touaty,J. Daghfous,R. Pariente
Effects of the administration of O2 on ventilation and blood gases in patients with chronic obstructive pulmonary disease during acute respiratory failure
Am Rev Respir Dis, 122 (1980), pp. 747-754 http://dx.doi.org/10.1164/arrd.1980.122.5.747
[178.]
J. Bott,M.P. Carroll,J.H. Conway,S.E.J. Keilty,E.M. Ward,A.M. Brown
Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease
Lancet, 341 (1993), pp. 1555-1557
[179.]
L. Brochard,J. Mancebo,M. Wysocki,F. Lofaso,G. Conti,A. Rauss
Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease
N Engl J Med, 333 (1995), pp. 817-822 http://dx.doi.org/10.1056/NEJM199509283331301
[180.]
N. Kramer,T.J. Meyer,J. Meharg,R.D. Cece,N.S. Hill
Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure
Am J Respir Crit Care Med, 151 (1995), pp. 1799-1806 http://dx.doi.org/10.1164/ajrccm.151.6.7767523
[181.]
F. Barbé,B. Togores,M. Rubí,S. Pons,A. Maimó,A.G.N. Agustí
Non-invasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary disease
Eur Respir J, 9 (1996), pp. 1240-1245
[182.]
S. Nava,N. Ambrosino,E. Clini,M. Prato,G. Orlando,M. Vitacca
Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease. A randomized, controlled trial
Ann Intern Med, 128 (1998), pp. 721-728
[183.]
P.K. Plant,J.L. Owen,M.W. Elliot
Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial
Lancet, 355 (2000), pp. 1931-1935
Copyright © 2001. Sociedad Española de Neumología y Cirugía Torácica
Idiomas
Archivos de Bronconeumología

Suscríbase al Newsletter

Opciones de artículo
Herramientas
Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí.

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?